NGI, YTI, and Ndaru Collaborate to Improve Early Screening for Thalassemia
Thalassemia is a genetic blood disorder that affects millions of people worldwide. It is particularly prevalent in Southeast Asia, including Indonesia, where an estimated 1 in 25 individuals carry the gene for thalassemia. Early detection and screening for thalassemia are crucial in order to provide appropriate treatment and support for affected individuals.
In an effort to improve early screening for thalassemia, three prominent organizations in Indonesia have joined forces. The National Genetics Institute (NGI), the Indonesian Thalassemia Foundation (YTI), and Ndaru, a digital health platform, have collaborated to develop a comprehensive screening program to identify individuals at risk for thalassemia.
NGI is a leading genetics research institute in Indonesia, specializing in the diagnosis and treatment of genetic disorders. YTI is a non-profit organization dedicated to raising awareness about thalassemia and providing support for individuals and families affected by the disease. Ndaru is a digital health platform that leverages technology to improve access to healthcare services for underserved communities.
Through this collaboration, NGI will provide genetic testing services to identify individuals carrying the gene for thalassemia. YTI will raise awareness about the importance of early screening and provide support for individuals who test positive for the disease. Ndaru will utilize its digital platform to facilitate the screening process and connect individuals with healthcare providers for further evaluation and treatment.
By combining their expertise and resources, NGI, YTI, and Ndaru aim to increase the number of individuals screened for thalassemia and ensure that those at risk receive the necessary care and support. This collaboration represents a significant step forward in the fight against thalassemia in Indonesia and underscores the importance of early detection and intervention in managing genetic disorders.
Moving forward, the three organizations plan to expand their screening program to reach more communities across Indonesia and continue their efforts to improve access to genetic testing and healthcare services for individuals at risk for thalassemia. Through their collective efforts, NGI, YTI, and Ndaru are making a positive impact on the lives of individuals affected by thalassemia and paving the way for a healthier future for all Indonesians.